Hyperthermia itself has cytotoxic effects and can potentiate antineoplastic. Among patients with stage iii epithelial ovarian cancer, the addition of hipec to interval cytoreductive surgery resulted in longer recurrencefree survival and overall survival than surgery alone. Rationale for hyperthermic intraperitoneal chemotherapy hipec in ovarian cancer. We conducted a trial to investigate whether the addition of hyperthermic intraperitoneal chemotherapy hipec to interval cytoreductive surgery. Funding and disclosures supported by the dutch cancer society nki 20064176. Intraoperative hyperthermic intraperitoneal chemotherapy hipec.
Hyperthermic intraperitoneal chemotherapy with paclitaxel in advanced ovarian cancer hipecova the safety and scientific validity of this study is the responsibility of the study sponsor and investigators. When performed in conjunction with cytoreductive surgery crs, intraoperative hyperthermic intraperitoneal chemotherapy hipec is proven and medically necessary for treating the following conditions. Intraperitoneal chemotherapy ip and hyperthermic intraperitoneal chemotherapy hipec outline. And there are also studies focus on treatment for it, such as parp inhibitors 23,24, hyperthermic intraperitoneal chemotherapy 25 and nanotherapy, but until now, survival rate of ovarian. Treatment of newly diagnosed advancedstage ovarian cancer typically involves cytoreductive surgery and systemic chemotherapy. Surgery is the optimal treatment for earlystage ovarian cancer, and platinumbased chemotherapy followed by debulking surgery is the standard therapy for advanced ovarian cancer. To evaluate the clinical effect of intraperitoneal hyperthermic chemotherapy iphc in ovarian cancer patients. What is the role of hyperthermic intraperitoneal chemotherapy in the. The majority of patients with ovarian cancer oc receive an initial diagnosis of advanced disease that has spread from the ovaries to. Effects of intraperitoneal hyperthermic chemotherapy in. Our data indicate that cytoreductive surgery and hyperthermic intraperitoneal chemotherapy is feasible and associated with a reasonable morbidity rate and mortality rate in. Pdf background treatment of newly diagnosed advancedstage ovarian cancer typically involves cytoreductive surgery and systemic.
Bc cancer agency improving services and patientcentered care for fraser valley. Should hyperthermic intraperitoneal chemotherapy be the new. In this new context of hipec, crucial questions with cytoreductive surgery plus hipec in ovarian cancer are the modulation of systemic recurrence rate and site. Also known as hot chemotherapy, hipec is performed after the surgeon removes tumors or lesions from the abdominal area. Hyperthermic intraperitoneal chemotherapy hipec, also referred to as intraperitoneal hyperthermic chemotherapy iphc, has been proposed as an alternative for the treatment of cancers within the peritoneal cavity, including primary peritoneal mesothelioma and gastric cancer. Jun 28, 2004 our data indicate that cytoreductive surgery and hyperthermic intraperitoneal chemotherapy is feasible and associated with a reasonable morbidity rate and mortality rate in patients with peritoneal carcinomatosis and ovarian cancer. Hipec in recurrent ovarian cancer has been studied somewhat more extensively but largely in a retrospective manner with a variety of.
Hyperthermic intraperitoneal chemotherapy hipec is a single intraoperative approach that also targets the peritoneal surface. The role of heated intraperitoneal chemotherapy hipec in ovarian cancer. Hyperthermic intraperitoneal chemotherapy in ovarian cancer article pdf available in new england journal of medicine 3783. Diseasefree survival, overall survival, and side effects were compared with a control group of patients who refused a secondlook surgery and. When performed in conjunction with cytoreductive surgery crs, intraoperative hyperthermic intraperitoneal. This is referred to as early postoperative intraperitoneal chemotherapy epic. Ovarian canceroc is one of the most lethal gynecologic cancers with 22,440 new cases and 14,080 deaths anticipated by 2017 in the united states.
Gynecologic oncology group surgical procedures manual. Hyperthermic intraperitoneal chemotherapy and cytoreductive surgery in the management of peritoneal carcinomatosis rahul rajeev, mbbs, and kiran k. Hyperthermic intraperitoneal chemotherapy for ovarian cancer. Hyperthermic intraperitoneal chemotherapy hipec in conjunction with cytoreductive surgery crs holds promise as an adjunctive treatment strategy in malignancies affecting the peritoneal surface, effectively targeting remaining microscopic residual tumor. Bc scientists uncover new subtypes of ovarian cancer with new potential treatment strategies. Hipec increases concentrations of chemotherapy directly within the peritoneal cavity compared with the intravenous route and reduces the. When performed in conjunction with cytoreductive surgery crs, intraoperative hyperthermic intraperitoneal chemotherapy hipec. Importance hyperthermic intraperitoneal chemotherapy hipec and cytoreductive surgery have been shown to benefit selected patients with peritoneal carcinomatosis. In ip chemotherapy, the drugs cisplatin and paclitaxel are.
Chemotherapy for ovarian cancer intraperitoneal chemotherapy. A new trial shows for the first time that hipec improved outcomes for women with newly diagnosed advanced cancer too. Dietrich 1, 1 division of gynecologic oncology, university of kentucky, lexington, ky 40502, usa. Hyperthermic intraperitoneal chemotherapy hipec in newly. Early averagerisk colon cancer screening test temporarily. Intraoperative hyperthermic intraperitoneal chemotherapy. Patients with advanced epithelial ovarian cancer have a high incidence of peritoneal disease recurrence despite maximal efforts to surgically. Hyperthermic intraoperative peritoneal chemotherapy hipec is also done for other cancers that have spread to the. Jan 11, 2019 in the 1990s, cytoreductive surgery crs with hyperthermic intraperitoneal chemotherapy hipec emerged as a promising treatment for patients with peritoneal carcinomatosis from gastrointestinal and ovarian cancer without extraabdominal disease. Hyperthermic intraperitoneal chemotherapy and cytoreductive.
Effects of intraperitoneal hyperthermic chemotherapy in ovarian cancer ki sung ryu,a jae hoon kim,b hyun sun ko,c jin woo kim,c woong shick ahn,c yong gyu park,d seung jo kim,e and joon mo leec. In the setting of crs and hyperthermic intraperitoneal peroperative chemotherapy hipec, cisplatin has been used for intracavitary therapy of ovarian cancer in several phase ii studies37,38. Most ovarian cancers are either ovarian epithelial carcinomas cancer that begins in the cells on the surface of the ovary or malignant germ cell tumors cancer that begins in egg cells. Hyperthermic intraperitoneal chemotherapy hipec is a cancer treatment that involves filling the abdominal cavity with chemotherapy drugs that have been heated. Apr 17, 2019 ovarian cancer oc is one of the most lethal gynecologic cancers with 22,440 new cases and 14,080 deaths anticipated by 2017 in the united states. Mar, 2019 hipec hyperthermic intraperitoneal chemotherapy is the administration of heated chemotherapy meds into the peritoneum after surgery. Heated intraperitoneal chemotherapy in the management of.
Hyperthermic intraperitoneal chemotherapy hipec in conjunction with cytoreductive surgery crs holds promise as an adjunctive treatment strategy in malignancies affecting the peritoneal surface. The role of hyperthermic intraperitoneal chemotherapy hipec in. For patients with newly diagnosed, primary stage iii epithelial ovarian, fallopian tube or primary peritoneal carcinoma, hipec with crs should. The prognosis impact of hyperthermic intraperitoneal chemotherapy hipec plus cytoreductive surgery crs in advanced ovarian cancer. To the editor, we read with great interest the recently published article by van driel et al. In this procedure, warmed anti cancer drugs are infused and circulated in the peritoneal cavity abdomen for a short period of time. Pdf hyperthermic intraperitoneal chemotherapy in ovarian cancer. Intraperitoneal hyperthermic chemotherapy in ovarian cancer. How is hipec hyperthermic intraperitoneal chemotherapy used. Hipec has already been shown effective in recurrent ovarian cancer. Despite numerous recent advances in chemotherapy, the overall chance of chemotherapy being curative is still low, and the side effects are difficult for the. Hyperthermic intraoperative peritoneal chemotherapy hipec is also done for other cancers that have spread to the peritoneal surfaces of the abdomen after cytoreduction debulking surgery is completed, such as ovarian, colon, gastric and pancreatic cancers. Hyperthermic intraperitoneal chemotherapy the addition of hipec with cisplatin to cytoreductive surgery in stage iii ovarian cancer resulted in recurrencefree survival that was longer by 3.
Marys hospital between january 1994 and january 2000. The effect of age on the tolerability of intraperitoneal chemotherapy, complication rate, and survival in patients with ovarian cancer. Hyperthermic intraperitoneal chemotherapy in ovarian cancer. Ovarian cancer is the second most frequent malignant tumor of the female genital tract and the. In the 1990s, cytoreductive surgery crs with hyperthermic intraperitoneal chemotherapy hipec emerged as a promising treatment for patients with peritoneal carcinomatosis from. In the intentiontotreat analysis, events of disease recurrence or death occurred in 110 of the 123 patients 89% who underwent cytoreductive surgery without hipec surgery group and in 99 of. We conducted a trial to investigate whether the addition of hyperthermic intraperitoneal chemotherapy hipec to in terval cytoreductive surgery would improve outcomes among patients who were re. Hyperthermic intraperitoneal chemotherapy hipec is a treatment used. Sonke, md, phd 2 patients with advanced epithelial ovarian cancer have a high incidence of peritoneal disease recurrence despite maximal efforts to. Hyperthermic intraperitoneal chemotherapy hipec in. Peritonectomy followed by hyperthermic intraperitoneal chemotherapy hipec is a combined treatment approach for peritoneal carcinomatosis that, up until 2017, was not commonly used for ovarian cancer. For women who have stage iii ovarian cancer cancer that has not spread outside the abdomen and whose cancers were optimally debulked no tumors larger than 1 cm after surgery, intraperitoneal ip chemotherapy might be given in addition to systemic chemo paclitaxel given in a vein.
The prognosis impact of hyperthermic intraperitoneal chemotherapy. We conducted a trial to investigate whether the addition of hyperthermic intraperitoneal chemotherapy hipec to in terval cytoreductive surgery. Indications for hyperthermic intraperitoneal chemotherapy with. Hyperthermic intraperitoneal chemotherapy hipec and cytoreductive surgery crs in ovarian cancer.
Hipec cooperative program md anderson cancer center. A randomized phase 3 trial showed significant benefit in recurrence. Efficacy of hyperthermic intraperitoneal chemotherapy in. Hyperthermic intraperitoneal chemotherapy in advanced ovarian. Pharmacology of cancer chemotherapy drugs for hyperthermic. Hyperthermic intraperitoneal chemotherapy hipec in ovarian. Cytoreductive surgery and hyperthermic intraperitoneal. We investigated the effect of intraperitoneal hyperthermic perfusion chemotherapy as consolidation therapy in stage iiibiiic ovarian cancer, following cytoreductive surgery and systemic chemotherapy cisplatincyclophosphamidesix cycles. Hyperthermic intraperitoneal chemotherapy with paclitaxel.
Hyperthermic intraperitoneal chemotherapy hipec in newly diagnosed advanced ovarian cancer. Hyperthermic intraperitoneal chemotherapy in advanced. Statement by the kommission ovar of the ago study group on the use of hipec hyperthermic intraperitoneal chemotherapy to treat primary and recurrent ovarian cancer. Hyperthermic intraperitoneal chemotherapy with paclitaxel in. No significant differences between the hipec and control groups were observed in the incidence of adverse events of any grade. Hyperthermic intraperitoneal chemotherapy wikipedia. Jan 18, 2018 hyperthermic intraperitoneal chemotherapy in ovarian cancer article pdf available in new england journal of medicine 3783. For women who have stage iii ovarian cancer cancer that has not spread outside the abdomen and whose cancers were optimally debulked no tumors larger than 1 cm after surgery, intraperitoneal ip. First explored in ovarian malignancies in the 1980s, hyperthermic intraperitoneal chemotherapy hipec in conjunction with cytoreductive surgery crs has become central in controlling peritoneal disease and improving survival outcomes in selected patients with peritoneal surface malignancies 1.
Complete cytoreduction may improve survival in highly selected patients low tumor volume and no organ metastases. Death occurred in 50% of the hyperthermic intraperitoneal chemotherapy group vs 62% of the control group. Hyperthermic intraperitoneal chemotherapy hipec bc cancer. Pdf hyperthermic intraperitoneal chemotherapy hipec in. Hyperthermic intraperitoneal chemotherapy hipec appendix. Mar 16, 2018 hyperthermic intraperitoneal chemotherapy hipec in newly diagnosed advanced ovarian cancer.
Hyperthermic intraperitoneal chemotherapy in ovarian cancer article pdf available in new england journal of medicine. Intraoperative hyperthermic intraperitoneal chemotherapy in. Safety and potential benefit of hyperthermic intraperitoneal chemotherapy hipec in peritoneal carcinomatosis from primary or recurrent ovarian cancer. The prognosis impact of hyperthermic intraperitoneal. Peritonectomy followed by hyperthermic intraperitoneal chemotherapy hipec is a combined treatment approach for peritoneal carcinomatosis that, up until 2017, was not commonly used for ovarian cancer in australia.
How is hipec hyperthermic intraperitoneal chemotherapy. Hyperthermic intraperitoneal chemotherapy hipec in ovarian cancer. However, the main mode of recurrence of ovarian cancer is pc and it often remains a locoregional disease for a long time, confined to the peritoneum and intraabdominal viscera. Hyperthermic intraperitoneal chemotherapy for ovarian. We investigated the effect of intraperitoneal hyperthermic perfusion chemotherapy as consolidation therapy in stage iiibiiic ovarian cancer, following cytoreductive surgery and systemic. Pdf hyperthermic intraperitoneal chemotherapy in ovarian. Intraperitoneal hyperthermic chemoperfusion hipec or iphc is a type of hyperthermia therapy used in combination with surgery in the treatment of advanced abdominal cancers. Unique study compares cancer incidence and survival between first nations and nonfirst nations people in bc.
1491 1345 615 166 54 96 1491 735 358 1323 177 876 640 632 559 1203 892 86 817 1454 962 56 998 784 88 984 1452 1364 766 447 672 549 987 374 1035 1177 1020 1383